BrainStorm Granted Additional US Patent for Its Autologous Stem Cell Technology – Jewish Business News
|
BrainStorm Granted Additional US Patent for Its Autologous Stem Cell Technology
Jewish Business News BrainStorm Cell Therapeutics (otcqb:BCLI), a developer of adult stem cell technologies for neurodegenerative diseases, today announced that the U.S. Patent and Trademark Office has granted the company an additional patent for its autologous stem cell … BrainStorm wins additional US patent for its autologous stem cell technologyMENAFN.COM |
